Back to Journals » Vascular Health and Risk Management » Volume 16

Understanding the early mortality benefit observed in the PARADIGM-HF trial: considerations for the management of heart failure with sacubitril/valsartan

Total article views   HTML views PDF downloads Totals
9,224 Dovepress* 6,484+ 1,780 8,264
PubMed Central* 2,740 600 3,340
Totals 9,224 2,380 11,604
*Since 16 January 2020

View citations on PubMed Central and Google Scholar